Several Nav1.7 selective blockers have been developed; however, because Nav1.7 is expressed in both the somatosensory nervous system and the sympathetic nervous system, these potential analgesic drugs can be associated with autonomic dysfunction (8). Here, SCN9A is linked to Abnormal autonomic nervous system physiology.